• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络的 TNAPP 算法改善了临床实践中的甲状腺结节管理:一项回顾性验证研究。

The TNAPP web-based algorithm improves thyroid nodule management in clinical practice: A retrospective validation study.

机构信息

Interdisciplinary Department of Medicine, Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, School of Medicine, University of Bari "Aldo Moro", Bari, Italy.

Department of Emergency and Organ Transplantation, Section of Pathological Anatomy, University of Bari "Aldo Moro", Bari, Italy.

出版信息

Front Endocrinol (Lausanne). 2023 Jan 27;13:1080159. doi: 10.3389/fendo.2022.1080159. eCollection 2022.

DOI:10.3389/fendo.2022.1080159
PMID:36778596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9911894/
Abstract

BACKGROUND

The detection of thyroid nodules has been increasing over time, resulting in an extensive use of fine-needle aspiration (FNA) and cytology. Tailored methods are required to improve the management of thyroid nodules, including algorithms and web-based tools.

STUDY AIMS

To assess the performance of the Thyroid Nodule App (TNAPP), a web-based, readily modifiable, interactive algorithmic tool, in improving the management of thyroid nodules.

METHODS

One hundred twelve consecutive patients with 188 thyroid nodules who underwent FNA from January to December 2016 and thyroid surgery were retrospectively evaluated. Neck ultrasound images were collected from a thyroid nodule registry and re-examined to extract data to run TNAPP. Each nodule was evaluated for ultrasonographic risk and suitability for FNA. The sensitivity, specificity, positive and negative predictive values, and overall accuracy of TNAPP were calculated and compared to the diagnostic performance of the other two algorithms by the American Association of Clinical Endocrinology/American College of Endocrinology/Associazione Medici Endocrinologi AACE/ACE/AME), which it was derived from the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS).

RESULTS

TNAPP performed better in terms of sensitivity (>80%) and negative predictive value (68%) with an overall accuracy of 50.5%, which was similar to that found with the AACE/ACE/AME algorithm. TNAPP displayed a slightly better performance than AACE/ACE/AME and ACR TI-RADS algorithms in selectively discriminating unnecessary FNA for nodules with benign cytology (TIR 2 - Bethesda class II: TNAPP 32% vs. AACE/ACE/AME 31% vs. ACR TI-RADS 29%). The TNAPP reduced the number of missed diagnoses of thyroid nodules with suspicious and highly suspicious cytology (TIR 4 + TIR 5 - Bethesda classes V + VI: TNAPP 18% vs. AACE/ACE/AME 26% vs. ACR TI-RADS 20.5%). A total of 14 nodules that would not have been aspirated were malignant, 13 of which were microcarcinomas (92.8%).

DISCUSSION

The TNAPP algorithm is a reliable, easy-to-learn tool that can be readily employed to improve the selection of thyroid nodules requiring cytological characterization. The rate of malignant nodules missed because of inaccurate characterization at baseline by TNAPP was lower compared to the other two algorithms and, in almost all the cases, the tumors were microcarcinomas. TNAPP's use of size >20 mm as an independent determinant for considering or recommending FNA reduced its specificity.

CONCLUSION

TNAPP performs well compared to AACE/ACE/AME and ACR-TIRADS algorithms. Additional retrospective and, ultimately, prospective studies are needed to confirm and guide the development of future iterations that incorporate different risk stratification systems and targets for diagnosing malignancy while reducing unnecessary FNA procedures.

摘要

背景

随着时间的推移,甲状腺结节的检出率一直在增加,导致细针抽吸(FNA)和细胞学检查广泛应用。需要制定有针对性的方法来改善甲状腺结节的管理,包括算法和基于网络的工具。

研究目的

评估 Thyroid Nodule App(TNAPP)的性能,这是一种基于网络的、易于修改的、交互式算法工具,用于改善甲状腺结节的管理。

方法

回顾性评估了 2016 年 1 月至 12 月期间接受 FNA 检查的 112 例连续患者的 188 个甲状腺结节和甲状腺手术。从甲状腺结节登记处收集颈部超声图像,并重新检查以提取数据运行 TNAPP。对每个结节进行超声风险评估和是否适合进行 FNA。计算 TNAPP 的敏感性、特异性、阳性和阴性预测值以及总准确率,并与其他两种算法(美国临床内分泌医师协会/美国内分泌学会/意大利内分泌医师协会 AACE/ACE/AME)的诊断性能进行比较,该算法源自美国放射学会甲状腺成像报告和数据系统(ACR TI-RADS)。

结果

TNAPP 在敏感性(>80%)和阴性预测值(68%)方面表现更好,总准确率为 50.5%,与 AACE/ACE/AME 算法相似。TNAPP 在选择性区分良性细胞学(TIR 2- Bethesda 分类 II)的结节中不必要的 FNA 方面的性能略优于 AACE/ACE/AME 和 ACR TI-RADS 算法(TNAPP 32%对 AACE/ACE/AME 31%对 ACR TI-RADS 29%)。TNAPP 减少了可疑和高度可疑细胞学(TIR 4+TIR 5- Bethesda 分类 V+VI)的甲状腺结节漏诊数量(TNAPP 18%对 AACE/ACE/AME 26%对 ACR TI-RADS 20.5%)。总共 14 个原本不会进行抽吸的结节是恶性的,其中 13 个是微癌(92.8%)。

讨论

TNAPP 算法是一种可靠的、易于学习的工具,可用于改善需要细胞学特征的甲状腺结节的选择。与其他两种算法相比,TNAPP 基线特征不准确导致恶性结节漏诊的比例较低,而且在几乎所有情况下,肿瘤都是微癌。TNAPP 将大小>20mm 作为考虑或推荐 FNA 的独立决定因素,降低了其特异性。

结论

与 AACE/ACE/AME 和 ACR-TIRADS 算法相比,TNAPP 表现良好。需要进行额外的回顾性和最终的前瞻性研究,以确认和指导开发未来的迭代,该迭代将纳入不同的风险分层系统和诊断恶性肿瘤的目标,同时减少不必要的 FNA 程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/0c825ba03a52/fendo-13-1080159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/48129f9a4de2/fendo-13-1080159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/c1481ae77b3f/fendo-13-1080159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/5d2531ce3763/fendo-13-1080159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/f32234420f7a/fendo-13-1080159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/0c825ba03a52/fendo-13-1080159-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/48129f9a4de2/fendo-13-1080159-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/c1481ae77b3f/fendo-13-1080159-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/5d2531ce3763/fendo-13-1080159-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/f32234420f7a/fendo-13-1080159-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31c4/9911894/0c825ba03a52/fendo-13-1080159-g005.jpg

相似文献

1
The TNAPP web-based algorithm improves thyroid nodule management in clinical practice: A retrospective validation study.基于网络的 TNAPP 算法改善了临床实践中的甲状腺结节管理:一项回顾性验证研究。
Front Endocrinol (Lausanne). 2023 Jan 27;13:1080159. doi: 10.3389/fendo.2022.1080159. eCollection 2022.
2
Comparison of different systems of ultrasound (US) risk stratification for malignancy in elderly patients with thyroid nodules. Real world experience.老年甲状腺结节患者不同超声(US)恶性风险分层系统的比较。真实世界经验。
Endocrine. 2020 Aug;69(2):331-338. doi: 10.1007/s12020-020-02295-4. Epub 2020 Apr 14.
3
Malignancy risk stratification and FNA recommendations for thyroid nodules: A comparison of ACR TI-RADS, AACE/ACE/AME and ATA guidelines.甲状腺结节的恶性风险分层和 FNA 建议:ACR TI-RADS、AACE/ACE/AME 和 ATA 指南的比较。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102625. doi: 10.1016/j.amjoto.2020.102625. Epub 2020 Jun 24.
4
American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool.美国临床内分泌学会和意大利内分泌学会甲状腺结节算法工具。
Endocr Pract. 2021 Jul;27(7):649-660. doi: 10.1016/j.eprac.2021.04.007. Epub 2021 Jun 3.
5
American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool.美国临床内分泌学会和意大利内分泌学会甲状腺结节算法工具。
Endocr Metab Immune Disord Drug Targets. 2021;21(11):2104-2115. doi: 10.2174/187153032111211230225617.
6
Does a higher American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) score forecast an increased risk of malignancy? A correlation study of ACR TI-RADS with FNA cytology in the evaluation of thyroid nodules.美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS)评分较高是否预示恶性风险增加?评估甲状腺结节时 ACR TI-RADS 与细针穿刺细胞学的相关性研究。
Cancer Cytopathol. 2020 Jul;128(7):470-481. doi: 10.1002/cncy.22254. Epub 2020 Feb 20.
7
Comparison of Different Ultrasound Classification Systems of Thyroid Nodules for Identifying Malignant Potential: A Cross-sectional Study.不同甲状腺结节超声分类系统对良恶性潜能鉴别的比较:一项横断面研究。
Clinics (Sao Paulo). 2021 Jan 20;76:e2126. doi: 10.6061/clinics/2021/e2126. eCollection 2021.
8
Diagnostic Performance of Six Ultrasound Risk Stratification Systems for Thyroid Nodules: A Systematic Review and Network Meta-Analysis.六种甲状腺结节超声风险分层系统的诊断性能:系统评价和网络荟萃分析。
AJR Am J Roentgenol. 2023 Jun;220(6):791-803. doi: 10.2214/AJR.22.28556. Epub 2023 Feb 8.
9
Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules.ATA、AACE/ACE/AME 和 ACR TI-RADS 超声分类在识别细胞学高危甲状腺结节方面的性能差异。
Eur J Endocrinol. 2018 Jun;178(6):595-603. doi: 10.1530/EJE-18-0083. Epub 2018 Apr 6.
10
Assessment of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS™) with modification of the management recommendations for pediatric thyroid nodules.评估美国放射学院甲状腺影像报告和数据系统(ACR TI-RADS™),并修改儿科甲状腺结节的管理建议。
Pediatr Radiol. 2024 Aug;54(9):1476-1485. doi: 10.1007/s00247-024-05982-w. Epub 2024 Jul 10.

引用本文的文献

1
Computer-interpretable guidelines: electronic tools to enhance the utility of thyroid nodule clinical practice guidelines and risk stratification tools.计算机可解释的指南:电子工具,用于增强甲状腺结节临床实践指南和风险分层工具的实用性。
Front Endocrinol (Lausanne). 2023 Aug 15;14:1228834. doi: 10.3389/fendo.2023.1228834. eCollection 2023.

本文引用的文献

1
Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?用于甲状腺结节特征描述的人工智能:我们目前的进展如何?
Cancers (Basel). 2022 Jul 10;14(14):3357. doi: 10.3390/cancers14143357.
2
Management of thyroid nodules.甲状腺结节的管理。
Lancet Diabetes Endocrinol. 2022 Jul;10(7):540-548. doi: 10.1016/S2213-8587(22)00139-5.
3
Diagnosis of thyroid nodules.甲状腺结节的诊断。
Lancet Diabetes Endocrinol. 2022 Jul;10(7):533-539. doi: 10.1016/S2213-8587(22)00101-2.
4
A Retrospective Study of Clinicopathologic Outcomes of Nodules With Hürthle Cell Cytology and the Thyroid Nodule App (TNAPP) Ultrasound Recommendations.具有 Hurthle 细胞细胞学特征的结节的临床病理结局回顾性研究及甲状腺结节评估应用(TNAPP)超声推荐。
Endocr Pract. 2022 Jun;28(6):593-598. doi: 10.1016/j.eprac.2022.03.011. Epub 2022 Mar 17.
5
The Role of CEUS in the Evaluation of Thyroid Cancer: From Diagnosis to Local Staging.对比增强超声在甲状腺癌评估中的作用:从诊断到局部分期
J Clin Med. 2021 Sep 30;10(19):4559. doi: 10.3390/jcm10194559.
6
Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the Literature.甲状腺结节的特征描述:如何评估恶性风险。文献综述
Diagnostics (Basel). 2021 Jul 30;11(8):1374. doi: 10.3390/diagnostics11081374.
7
American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool.美国临床内分泌学会和意大利内分泌学会甲状腺结节算法工具。
Endocr Pract. 2021 Jul;27(7):649-660. doi: 10.1016/j.eprac.2021.04.007. Epub 2021 Jun 3.
8
History of artificial intelligence in medicine.医学人工智能的历史。
Gastrointest Endosc. 2020 Oct;92(4):807-812. doi: 10.1016/j.gie.2020.06.040. Epub 2020 Jun 18.
9
Artificial Intelligence in Cardiology: Present and Future.人工智能在心脏病学中的应用:现状与未来。
Mayo Clin Proc. 2020 May;95(5):1015-1039. doi: 10.1016/j.mayocp.2020.01.038.
10
Artificial Intelligence: The Future for Diabetes Care.人工智能:糖尿病护理的未来。
Am J Med. 2020 Aug;133(8):895-900. doi: 10.1016/j.amjmed.2020.03.033. Epub 2020 Apr 20.